DEEPLEX
LIVE

Serial Number

79184029

Owner

GENOSCREEN

Attorney

CHAI IM

Filing Date

Aug 11, 2015

Add to watchlist:

No watchlists yet
View on USPTO

DEEPLEX Trademark

Serial Number: 79184029 • Registration: 5319161

DEEPLEX is a trademark filed by GENOSCREEN on August 11, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

GENOSCREEN (3 trademarks)

1 rue du Professeur Calmette
F-59000 LILLE , FR

Entity Type: 99

Trademark Details

Filing Date

August 11, 2015

Registration Date

October 31, 2017

Published for Opposition

August 15, 2017

Goods & Services

[ Scientific apparatus and instruments for use in science, research and industry, namely, scales, sequencers, analyzers and computer hardware for measuring, testing and analyzing blood and other bodily fluid, water, air, soils, food flora metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomic, genetics, and life sciences; ] scientific apparatus kits comprised of scales, sequencers, analyzers and computer hardware for measuring, testing and analyzing blood and other bodily fluid flora, metagenomes, microorganisms, microbiota or transcriptomics, and reagents for DNA extraction, DNA amplification, sequencing libraries preparation and sequencing in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomics, genetics, and life sciences; [ analytical instruments, namely, scales, sequencers, analyzers and computer hardware for measuring, testing and analyzing blood and other bodily fluid, water, air, soils, food flora metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomic, genetics, and life sciences; ] [ data processors; computer programs and software for research, testing and analysis in the fields of science, biology, biotechnology, biochemistry, genomics, proteomics, transcriptomics, genetics, life sciences, cloning, human health, diagnostics, agri-food and in the processing of biological data; ] computer programs for scientific analysis of genetic sequences and biological platelets for use in scientific research; computer programs for identifying DNA, detecting diseases, analyzing data in the agri-food field, and testing and developing drugs [ ; diagnostic apparatus, not for medical use, namely, sequencers, analyzers and computer hardware, diagnostics apparatus for testing food, water, air, soils, blood and other bodily fluids, diagnostics apparatus for DNA analysis; measuring instruments, namely, electronic quantity indicators for measuring blood and other bodily fluids; DNA chips ]

[ Provision of access to databases; providing access to on-line computer databases; rental of access time to global computer networks; ] providing access to computer databases containing information based on human genome sequencer results; providing internet access to electronic libraries of biological markers; providing multiple user access to proprietary collections of information about biological markers by means of global computer information networks [ ; provision of access to a global computer network; providing user access to computer programs in data networks; provision of access to data or documents stored electronically in central files for remote consultation ]

[ Medical and veterinary apparatus and instruments, namely, sequencers and analyzers for measuring, testing and analyzing blood and other bodily fluid, water, air, soils, food flora metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomics, genetics, and life sciences; medical diagnostic apparatus for use in testing in the field of infectious diseases, tuberculosis, cancer and neurodegenerative diseases, medical diagnostic apparatus for use in testing in the field of infectious diseases, tuberculosis, cancer and neurodegenerative diseases, diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing in the field of infectious diseases, tuberculosis, cancer and neurodegenerative diseases ]

[ Evaluations, analyses, scientific research and technological testing services of flora, metagenomes, microorganisms, microbiota or transcriptomes in the field of pharmacy, chemistry, biotechnology, biochemistry, genomics, bacteriology, transcriptomics, genetics, and life sciences; biomedical research, and biological, medical and veterinary product development, gene expression analysis and protein profiling for scientific research purposes; providing laboratory research services in the field of gene expression and protein profiling, namely, cancer, infectious diseases, tuberculosis, Alzheimer biology; ] genotyping services for scientific research and analysis purposes and genotyping based on biological markers for scientific research and analysis purposes; design and development of programming databases in the fields of pharmaceuticals, biology, agri-food, biotechnology, biochemistry, genomics, transcriptomics, genetics and life sciences; clinical laboratory testing services, namely, gene sequencing-based testing services with a view to research relating to genome sequencing of plants and animals, micro-organisms, sequencing of DNA or RNA and epigenetic sequencing; development and updating of computer programs designed for scientific analysis of genetic sequences, genetic sequencing of the genes of individuals and cohorts; electronic data storage and computer programming services for publishing data in a computer science environment designed for bioinformatics; bioinformatics computer engineering services; laboratory research services in the field of large-scale DNA sequencing; development and updating of data management systems; database design and development and design and development of computer applications for general and biological data processing; scientific research, development and validation of micro-satellite and mini-satellite genetic markers; scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human animal and micro-organisms, namely, scientific development and validation of micro-satellite and mini-satellite markers; scientific laboratory services, namely, scientific services in the field of genomics for use in laboratories working on all kinds genomes including human animal, micro-organisms, namely, identification, typing, tracing, analysis, creation of a bank and a database, treatments resistance prediction, whole genome sequencing and complete flora; scientific research, mutation detection and identification of microorganisms and mini-satellite markers; scientific research, namely, mutation detection and identification of microorganisms; genotyping services for research or analyses purposes; development and testing of computer databases, software, algorithms and computing methods for generating and analyzing biological, genetic and epidemiological data; scientific research and development services in the fields of diagnostic methods, antibody technology, and gene expression systems; [ scientific research and development services; medical laboratory services; ] scientific laboratory services, namely, scientific services in the field of genomics for use in laboratories working on all kinds genomes, including human animal and micro-organisms, namely, scientific development and validation of micro-satellite and mini-satellite markers; scientific laboratory services, namely, scientific services in the field of genomics for use in laboratories working on all kinds genomes including human animal, micro-organisms, namely, identification, typing, tracing, analysis, creation of a bank and a database, treatments resistance prediction, whole genome sequencing and complete flora; scientific research, scientific research services, namely, mutation detection and identification of microorganisms and mini-satellite markers

Filing History

INTERNATIONAL REGISTRATION RENEWED
Oct 9, 2025 RNWL
PARTIAL INVALIDATION PROCESSED BY THE IB
Sep 27, 2025 INNP
LIMITATION OF GOODS RECEIVED FROM IB
Sep 26, 2025 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Aug 29, 2025 LIMG
GENERIC MADRID TRANSACTION SENT TO IB
Jul 11, 2025 XXSS
GENERIC MADRID TRANSACTION CREATED
Jul 11, 2025 XXCR
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jul 10, 2025 INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jul 9, 2025 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 4, 2025 INPS
INVALIDATION PROCESSED
Jul 4, 2025 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 14, 2025 INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 6, 2025 INPR
SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Aug 6, 2024 NA15
REGISTERED - SEC. 15 ACKNOWLEDGED
Aug 6, 2024 15AK
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Aug 6, 2024 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Aug 6, 2024 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 15, 2024 APRE
TEAS SECTION 71 RECEIVED
Oct 30, 2023 ES71
TEAS SECTION 15 RECEIVED
Oct 30, 2023 E15R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 21, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 21, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 21, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 21, 2023 COAR
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 31, 2022 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 27, 2020 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 30, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 1, 2018 FICS
FINAL DISPOSITION PROCESSED
Feb 1, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 31, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2017 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 25, 2017 OPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Aug 11, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 9, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 9, 2017 OPNR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 26, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 26, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2017 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 7, 2017 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 5, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 12, 2017 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
May 12, 2017 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
May 12, 2017 GNCF
ACTION CONTINUING A FINAL - COMPLETED
May 12, 2017 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2017 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 3, 2017 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 3, 2016 GNFN
FINAL REFUSAL E-MAILED
Nov 3, 2016 GNFR
FINAL REFUSAL WRITTEN
Nov 3, 2016 CNFR
ASSIGNED TO EXAMINER
Oct 18, 2016 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 14, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 14, 2016 CRFA
ASSIGNED TO LIE
Oct 2, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 23, 2016 TROA
REFUSAL PROCESSED BY IB
May 14, 2016 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 23, 2016 RFCS
REFUSAL PROCESSED BY MPU
Mar 23, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 23, 2016 RFCR
NON-FINAL ACTION WRITTEN
Mar 22, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 15, 2016 MAFR
ASSIGNED TO EXAMINER
Mar 10, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 10, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 3, 2016 REPR